Zobrazeno 1 - 10
of 73
pro vyhledávání: '"A M, Mantia"'
Autor:
Thomas Powles, Laurence Albiges, David F McDermott, Michael B Atkins, Toni K Choueiri, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Martin H Voss, Hans J Hammers, Chung-Han Lee, Robert J Motzer, Yoshihiko Tomita, Nizar M Tannir, Meredith M Regan, Charlene M Mantia, Lisa Rosenblatt, Opeyemi A Jegede
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Immunotherapy can be associated with prolonged disease control even after cessation of treatment without the need for further cancer-directed therapy. Treatment-related adverse events (TRAEs) can also persist after discontinuation of thera
Externí odkaz:
https://doaj.org/article/e929a9c890ec467cac7b04eb3f99fada
Autor:
Erin K. Tagai, Gina M. Mantia‐Smaldone, Andrew Belfiglio, Christina S. Chu, Emmanuel Lapitan, Heather Santos, Enrique Hernandez, David B. Sarwer, Suzanne M. Miller
Publikováno v:
Obesity Science & Practice, Vol 9, Iss 6, Pp 661-669 (2023)
Abstract Objective Type 1 endometrial cancer (EC) survivors who are overweight or obese are at increased risk of comorbidities and reduced quality of life. Lifestyle modification interventions (e.g., healthy eating, exercise) may help these women red
Externí odkaz:
https://doaj.org/article/40126958405f46f098f6183c13a3aa59
Autor:
James Larkin, Jedd Wolchok, David F McDermott, Michael A Postow, Ahmad A Tarhini, Michael B Atkins, F Stephen Hodi, Corey Ritchings, Brian Stwalley, Andriy Moshyk, Meredith M Regan, Charlene M Mantia, Lillian Werner, Sandra Re, Wim van Dijck
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/d544047750af455e9720b9d2c98d7dc4
Autor:
Sean Cronin, Nishat Ahmed, Amaranta D. Craig, Stephanie King, Min Huang, Christina S. Chu, Gina M. Mantia-Smaldone
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 560 (2022)
Non-Gestational Ovarian Choriocarcinoma (NGOC) is an extremely rare ovarian tumor, with an incidence of less than 0.6% of malignant ovarian germ cell tumors. Its close pathologic resemblance to Gestational Ovarian Choriocarcinoma (GOC), however, requ
Externí odkaz:
https://doaj.org/article/2161229ddbc3431885de0531e39fb9c4
Autor:
David F. McDermott, Michael B. Atkins, Brian Stwalley, Viviana Del Tejo, Stephen Huo, Laurence Albiges, Bernard Escudier, Hans J. Hammers, Brian I. Rini, Toni K. Choueiri, Elizabeth R. Plimack, Martin H. Voss, Yoshihiko Tomita, Chung-Han Lee, Nizar M. Tannir, Robert J. Motzer, Lillian Werner, Thomas Powles, Charlene M. Mantia, Opeyemi A. Jegede, Meredith M. Regan
Supplementary Data from Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e49ca13be123ef92c935f63a88bc82d
https://doi.org/10.1158/1078-0432.22483101.v1
https://doi.org/10.1158/1078-0432.22483101.v1
Autor:
Steffi Oesterreich, Robert P. Edwards, Esther Elishaev, Adrian V. Lee, Karen McLean, Kunle Odunsi, Gina M. Mantia-Smaldone, Paul Haluska, Uma Chandran, Soumya Luthra, Yongseok Park, George Tseng, Alec Christie, Tianzhou Ma, Michelle M. Boisen, Matthew J. Sikora, Courtney L. Andersen
Purpose: High-grade serous ovarian cancer (HGSOC) is an aggressive disease with few available targeted therapies. Despite high expression of estrogen receptor-alpha (ERα) in approximately 80% of HGSOC and some small but promising clinical trials of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b69dc9f515b57d93b1ffab40c1c00e7
https://doi.org/10.1158/1078-0432.c.6526559.v1
https://doi.org/10.1158/1078-0432.c.6526559.v1
Autor:
George Coukos, Rosemarie Mick, Daniel J. Powell, Drew A. Torigian, Brian J. Czerniecki, Michael Kalos, Bruce L. Levine, Harvey L. Nisenbaum, Lori Smith, Gina M. Mantia-Smaldone, Kathleen Montone, Nikolaos Svoronos, Gregory T. Motz, Andrea R. Hagemann, Janos Tanyi, Lana E. Kandalaft, Cheryl Lai-Lai Chiang
Supplementary Materials, Methods, Figures and Table legends - PDF file 87K, Supplementary file giving details of supplementary materials and methods, figure legends and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f923f4386446ea525ea7321c30f028
https://doi.org/10.1158/1078-0432.22447283.v1
https://doi.org/10.1158/1078-0432.22447283.v1
Autor:
George Coukos, Rosemarie Mick, Daniel J. Powell, Drew A. Torigian, Brian J. Czerniecki, Michael Kalos, Bruce L. Levine, Harvey L. Nisenbaum, Lori Smith, Gina M. Mantia-Smaldone, Kathleen Montone, Nikolaos Svoronos, Gregory T. Motz, Andrea R. Hagemann, Janos Tanyi, Lana E. Kandalaft, Cheryl Lai-Lai Chiang
Supplementary Figure S2 - PDF file 84K, Phenotype of DCs following lysate-pulsing (i.e. HOCl-L, UVB-L or FTL), and activation with LPS and IFN-gamma. Unpulsed, mature (mDC) or immature DCs (iDC) served as controls. Data was presented as mean plus-min
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88f1ff9d27bf0b3b2d47b6ad36b462f2
https://doi.org/10.1158/1078-0432.22447292.v1
https://doi.org/10.1158/1078-0432.22447292.v1
Autor:
George Coukos, Rosemarie Mick, Daniel J. Powell, Drew A. Torigian, Brian J. Czerniecki, Michael Kalos, Bruce L. Levine, Harvey L. Nisenbaum, Lori Smith, Gina M. Mantia-Smaldone, Kathleen Montone, Nikolaos Svoronos, Gregory T. Motz, Andrea R. Hagemann, Janos Tanyi, Lana E. Kandalaft, Cheryl Lai-Lai Chiang
Supplementary Table S1 - PDF file 191K, Cytokine and chemokine productions from DCs of ovarian cancer subjects that were loaded with HOCl-oxidized autologous whole tumor lysate and matured with LPS and IFN-gamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea66dfd35c14b100fa69edb35bb59b9
https://doi.org/10.1158/1078-0432.22447280.v1
https://doi.org/10.1158/1078-0432.22447280.v1
Autor:
George Coukos, Rosemarie Mick, Daniel J. Powell, Drew A. Torigian, Brian J. Czerniecki, Michael Kalos, Bruce L. Levine, Harvey L. Nisenbaum, Lori Smith, Gina M. Mantia-Smaldone, Kathleen Montone, Nikolaos Svoronos, Gregory T. Motz, Andrea R. Hagemann, Janos Tanyi, Lana E. Kandalaft, Cheryl Lai-Lai Chiang
Purpose: Whole tumor lysates are promising antigen sources for dendritic cell (DC) therapy as they contain many relevant immunogenic epitopes to help prevent tumor escape. Two common methods of tumor lysate preparations are freeze-thaw processing and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015766474701c5816d40b182df9252fc
https://doi.org/10.1158/1078-0432.c.6521027.v1
https://doi.org/10.1158/1078-0432.c.6521027.v1